Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for embedding and releasing DNA nano-origami structures as drug carriers using DAPI embedding and releasing

An origami structure and nanotechnology, which can be used in pharmaceutical formulations, medical preparations with inactive ingredients, fluorescence/phosphorescence, etc., and can solve the problems of expensive reagent ordering, complicated experimental design and operation, etc.

Active Publication Date: 2018-01-16
智玺那诺(上海)生物科技有限责任公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In this process, the experimental design and operation are complicated, and the ordering of reagents is expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for embedding and releasing DNA nano-origami structures as drug carriers using DAPI embedding and releasing

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Add 12 μL of circular DNA (2 μM, sequence: 5'TATGCCCAGCCCTGTAAGATGAAGATAGCGCACAATGGTCGGATTCTCAACTCGTATTCTCAACTCGTATTCTCAACTCGTCCTGCCCTμL) to 16 μL of primer DNA (1 μM, sequence: 5'CCAGCCTAAGAGTTGAGCA3'), dNTPs (4 μL, 10 mM), RCA buffer polymerase 4μL, 10 U / μL), the final volume of the mixed solution was 40μL. Then amplified in a 30°C water bath for 30 min. 40 μL of the obtained product was subjected to 10% PAGE electrophoresis, and then recovered by slicing gel to remove small fragments of DNA, redundant circular DNA and primer DNA. Take 3 μL of the recovered product, add 12 μL of milliQ water, and add stapled strands 1-3 (100 μM, the sequence is as follows:

[0016] 5'-CAGCCCTGTAAGATGAAGATAGCGTCTATGCC-3'

[0017] 5'-CCCTGACTCACAATGGTCGGATTCCGTCTCTG-3'

[0018] 5’-TCTCAACTTCAACTCGTATTCTCAACTCGTAT-3’) 1 μL each, 2 μL TAE buffer (10×, 125 mM Mg 2+ ), the total volume is 20 μL, the solution is mixed well, placed in a high temperature of 95 °C, and then gradually cooled...

Embodiment 2

[0020] Add 12 μL of circular DNA (2 μM, sequence: 5'TATGCCCAGCCCTGTAAGATGAAGATAGCGCACAATGGTCGGATTCTCAACTCGTATTCTCAACTCGTATTCTCAACTCGTCCTGCCCTμL) to 16 μL of primer DNA (1 μM, sequence: 5'CCAGCCTAAGAGTTGAGCA3'), dNTPs (4 μL, 10 mM), RCA buffer polymerase 4μL, 10 U / μL), the final volume of the mixed solution was 40μL. Then amplified in a 30°C water bath for 30 min. 40 μL of the obtained product was subjected to 10% PAGE electrophoresis, and then recovered by slicing gel to remove small fragments of DNA, redundant circular DNA and primer DNA. Take 3 μL of the recovered product, add 12 μL of milliQ water, and add stapled strands 1-3 (1 μM, the sequence is as follows:

[0021] 5'CAGCCCTGTAAGATGAAGATAGCGTCTATGCC3'

[0022] 5'CCCTGACTCACAATGGTCGGATTCCGTCTCTG3'

[0023] 5’TCTCAACTTCAACTCGTATTCTCAACTCGTAT3’, 1 μL each, 2 μL TAE buffer (10×, 125mMMg 2+ ), the total volume is 20 μL, the solution is mixed well, placed in a high temperature of 95 °C, and then gradually cooled to 25 °C....

Embodiment 3

[0025]Add 12 μL of circular DNA (2 μM, sequence: 5'TATGCCCAGCCCTGTAAGATGAAGATAGCGCACAATGGTCGGATTCTCAACTCGTATTCTCAACTCGTATTCTCAACTCGTCCTGCCCTμL) to 16 μL of primer DNA (1 μM, sequence: 5'CCAGCCTAAGAGTTGAGCA3'), dNTPs (4 μL, 10 mM), RCA buffer polymerase 4μL, 10 U / μL), the final volume of the mixed solution was 40μL. Then amplified in a 30°C water bath for 30 min. 40 μL of the obtained product was subjected to 10% PAGE electrophoresis, and then recovered by slicing gel to remove small fragments of DNA, redundant circular DNA and primer DNA. Take 3 μL of the recovered product, add 12 μL of milliQ water, and add stapled strands 1-3 (1 μM, the sequence is as follows:

[0026] 5'CAGCCCTGTAAGATGAAGATAGCGTCTATGCC3'

[0027] 5'CCCTGACTCACAATGGTCGGATTCCGTCTCTG3'

[0028] 5’TCTCAACTTCAACTCGTATTCTCAACTCGTAT3’, 1 μL each, 2 μL TAE buffer (10×, 125mMMg 2+ ), the total volume is 20 μL, the solution is mixed well, placed in a high temperature of 95 °C, and then gradually cooled to 25 °C. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a DNA nano-origami structure constructed by DNA rolling circle amplification technology and DNA origami. At the same time, the fluorescent dye DAPI with DNA double-strand binding characteristics and cell membrane penetration characteristics is used to mark and track the DNA nano-origami structure. Real-time monitoring and simulating the drug loading and sustained release process of DNA nano-origami structure as a drug carrier can also be used as a new fluorescence quantitative analysis method for biomolecular detection, such as early detection of tumors, postoperative monitoring and evaluation, and cell imaging, etc. field.

Description

technical field [0001] The invention belongs to the field of DNA nanotechnology development, functionalization and application of nanomaterials, and relates to a DNA nano-origami structure constructed by DNA rolling circle amplification technology and DNA origami, and utilizes DNA double-strand binding characteristics and cell membrane penetration characteristics at the same time The fluorescent dye DAPI marks and tracks the DNA nano-origami structure, realizes real-time monitoring and simulates the drug-loading and sustained-release process of the DNA nano-origami composite structure as a drug carrier, and can also be used as a new fluorescent quantitative analysis method for biomolecular detection , such as early detection of tumors, postoperative monitoring and evaluation, and cell imaging. Background technique [0002] In recent years, malignant tumors have become one of the major diseases that seriously endanger human health and life worldwide. Survey data show that in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N21/64A61K47/26
Inventor 何丹农颜娟胡冲娅金彩虹
Owner 智玺那诺(上海)生物科技有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com